Navigation Links
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Date:11/19/2008

and a predecessor investment bank, Hambrecht & Quist). From 1981 to 1996, he held positions, including partner, at several law firms including Cooley Godward LLP, Sidley Austin LLP and Davis Polk & Wardwell. He serves as a member of the board of directors and is chairman of the audit committee of Anacor Pharmaceuticals, Inc. Mr. Cleveland holds a J.D. from Northwestern University School of Law and an A.B. from Washington University in St. Louis.

"I am excited to join the board of directors of Sangamo BioSciences at this point in the company's development," commented Mr. Cleveland. "Sangamo has a successful business model designed to maximize the value of its ZFP technology platform by partnering non-core areas of its business as well as looking to establish new corporate partnerships in core ZFP Therapeutics. I look forward to contributing my experience to help position the company for continued growth and success."

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships wit
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
2. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
3. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
4. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
5. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
6. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
7. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)... to also Visit Detroit , ..., French Ambassador for International Investment, ...y, , , , ,What: Ambassador Appia is available to ...tiatives adopted by France to further develop the ...ation and development., , ,When: Available for Int...
(Date:11/24/2009)...Nov. 24 Two more prestigious unive...s leading online job board and careers site for li...olumbia University are now members of the job boar...stitutions. ,, The job board, www.biocareercen...ciences. While there are hundreds of life science ...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...release is available in German . , The enzyme ...o rapidly ,and efficiently detoxify chemical warfa...kyo subway attacks in 1995. A detailed understandi...mical reactions is ,necessary for efforts aiming t...s at the University of Frankfurt, the Bundeswehr I...
...ternet could be used as an early warning system fo...earchers from Stockholm Resilience Centre at Stock... , Ecosystem services such as water purification a...or all planetary life. However, these are threaten...us pressures like climate change and global market...
...N.Y. A new study answers a key question at the ve...all? , Researchers at Rensselaer Polytechnic Inst...ter, demonstrating that the competition and collab...rt hold the key to nanorod size. The researchers s...al reasons why nearly all nanorods have a diameter...
Other Biology Technology:Structure of enzyme against chemical warfare agents determined 2Internet can warn of ecological changes 2Internet can warn of ecological changes 3No small measure: Origins of nanorod diameter discovered 2
(Date:11/24/2009)...amed 12 new grant recipients for 2009. The awards,...across a broad spectrum of lupus research. All wer...ntial to drive scientific discovery to ultimately ...stemic lupus. , The 2009 grants go to both new a... and include interdisciplinary and highly promisin...
(Date:11/24/2009)...t may help gut bacteria bind to the gastrointestin...roducers to identify strains that are likely to be... interact with cells lining the gut to have a bene...he gut they are more likely to stick around long e...uge from the Institute of Food Research. IFR is a...
(Date:11/24/2009)...ass of ring-shaped protein motors has been uncover...nal Laboratory (Berkeley Lab) using a state-of-the...ced Light Source (ALS). These protein motors play ...and are vital to the survival of all biological ce...an papillomavirus, which has been linked to cervic...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Obesity does not worsen asthma but may reduce response to medications 47726 1Obesity does not worsen asthma but may reduce response to medications 47726 2American Chemistry Council Welcomes Call for Expedited FDA Review of BPA 47722 1American Chemistry Council Welcomes Call for Expedited FDA Review of BPA 47722 2Vision impairment costs billions lost in productivity 47719 1Vision impairment costs billions lost in productivity 47719 2
... , Washington, DCMay 28, 2008The 2008 American So...ce C. Evans Award is being presented to Jo Handels...ofessor of Plant Pathology and co-Director, Women ...niversity of Wisconsin, Madison. This award recogn...nd advancement of women in microbiology. , As a m...
... Washington, DC Researchers at Georgetown Unive...A, when applied to breast cancer cells, turns on g...to morph into endothelial cells. These cells can t...lood supply, promoting further tumor growth. , Th...line issue of PLoS ONE , is a proof of principle ...
... Although sickle cell disease is a single-gene di...dy published online July 14 by the Proceedings of...Children,s Hospital Boston and the Dana Farber Can...oad Institute of MIT and Harvard, report five gene...dicting sickle cell disease severity, perhaps even...
Other Biology News:American Society for Microbiology honors Jo Handelsman 2Vitamin A pushes breast cancer to form blood vessel cells 2Vitamin A pushes breast cancer to form blood vessel cells 3Gaining ground on sickle cell disease 2Gaining ground on sickle cell disease 3
Normal Human Serum from CHEMICON
AgarACE Enzyme from Promega
Immunoprecipitation Starter Pack from GE Healthcare, formerly Amersham Biosciences
STP3, T7 from Novagen
Biology Products: